NCT04162275View on ClinicalTrials.gov

A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Parkinson Disease
Interventions
DRUG

Finamine tablets

taken Finamine tablets orally

DRUG

Placebo tablets

taken Placebo tablets orally

Trial Locations (1)

050035

Shijiazhuang Yiling Pharmaceutical Co. Ltd, Shijiazhuang

All Listed Sponsors
lead

Yiling Pharmaceutical Inc.

INDUSTRY

NCT04162275 - A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China | Biotech Hunter | Biotech Hunter